By Danny Sullivan – Longevity.Technology –
A new study has found that semaglutide, better known as Ozempic and Wegovy, does not negatively impact brain health and may even provide benefits for cognition and nicotine dependence. The research, carried out by the University of Oxford and supported by the NIHR Oxford Health Biomedical Research Centre and the Medical Research Council, offers reassuring news for people using the popular obesity and diabetes medication, which has recently faced questions regarding its safety.
